- Home
- GSUN vs XBIO Comparison
GSUN vs XBIO Comparison
Compare GSUN & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- XBIO
- Stock Information
- Founded
- GSUN 1997
- XBIO N/A
- Country
- GSUN China
- XBIO United States
- Employees
- GSUN N/A
- XBIO N/A
- Industry
- GSUN Other Consumer Services
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GSUN Real Estate
- XBIO Health Care
- Exchange
- GSUN Nasdaq
- XBIO Nasdaq
- Market Cap
- GSUN 7.2M
- XBIO 5.8M
- IPO Year
- GSUN 2022
- XBIO N/A
- Fundamental
- Price
- GSUN $2.93
- XBIO $2.46
- Analyst Decision
- GSUN
- XBIO Hold
- Analyst Count
- GSUN 0
- XBIO 1
- Target Price
- GSUN N/A
- XBIO N/A
- AVG Volume (30 Days)
- GSUN 15.3K
- XBIO 6.6K
- Earning Date
- GSUN 04-08-2025
- XBIO 03-18-2025
- Dividend Yield
- GSUN N/A
- XBIO N/A
- EPS Growth
- GSUN N/A
- XBIO N/A
- EPS
- GSUN N/A
- XBIO N/A
- Revenue
- GSUN $10,159,020.00
- XBIO $2,500,284.00
- Revenue This Year
- GSUN N/A
- XBIO N/A
- Revenue Next Year
- GSUN N/A
- XBIO $27.78
- P/E Ratio
- GSUN N/A
- XBIO N/A
- Revenue Growth
- GSUN 65.04
- XBIO N/A
- 52 Week Low
- GSUN $2.21
- XBIO $2.45
- 52 Week High
- GSUN $9.93
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- GSUN 47.97
- XBIO 17.66
- Support Level
- GSUN $2.80
- XBIO $3.25
- Resistance Level
- GSUN $3.25
- XBIO $3.43
- Average True Range (ATR)
- GSUN 0.20
- XBIO 0.24
- MACD
- GSUN -0.02
- XBIO -0.08
- Stochastic Oscillator
- GSUN 36.00
- XBIO 0.71
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.